Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-4,562
Closed -$62K 409
2016
Q4
$62K Sell
4,562
-13,885
-75% -$212K ﹤0.01% 369
2016
Q3
$390K Sell
18,447
-6,287
-25% -$99.4K 0.01% 238
2016
Q2
$381K Hold
24,734
0.01% 229
2016
Q1
$408K Hold
24,734
0.01% 227
2015
Q4
$528K Buy
24,734
+990
+4% +$21.7K 0.02% 204
2015
Q3
$517K Buy
23,744
+11,243
+90% +$273K 0.02% 201
2015
Q2
$285K Buy
12,501
+4,681
+60% +$115K 0.01% 297
2015
Q1
$198K Buy
+7,820
New +$215K 0.01% 317

Other funds holding VXRT

Eagle Global Advisors's VXRT Position: Q1 2017 in Review

Eagle Global Advisors sold out of Vaxart (VXRT) in Q1 2017, closing a stake of 4,562 shares — an estimated $62K sold.

Eagle Global Advisors first reported a position in VXRT in Q1 2015 and held it in 8 quarters. The position peaked at $528K in Q4 2015. 37 funds tracked by Wall St. Rank hold VXRT as of Q1 2017.

  • Eagle Global Advisors reported no remaining Vaxart position as of Q1 2017 after selling out during the quarter.
  • Eagle Global Advisors sold 4,562 Vaxart shares in Q1 2017, an estimated $62K.
  • Eagle Global Advisors first reported a position in Vaxart in Q1 2015 and held it in 8 quarters.
  • Eagle Global Advisors's Vaxart position peaked at $528K in Q4 2015.
  • 37 funds tracked by Wall St. Rank held Vaxart as of Q1 2017.

Based on Eagle Global Advisors's 13F filing for Q1 2017, filed 9 May 2017.